袗胁褌芯褉写褘遥 卸邪褉懈褟谢邪薪褘屑写邪褉褘
Cho, W.C.
袘邪褉谢褘覜 卸邪褉懈褟谢邪薪褘屑写邪褉
24
袘械谢褋械薪写褨谢褨泻 卸褘谢写邪褉褘
5
袞邪褉懈褟谢邪薪褘屑 褌爷褉谢械褉褨
3
2026 (2)
- Global burden of lower respiratory infections and aetiologies, 1990鈥�2023: a systematic analysis for the Global Burden of Disease Study 2023
- Global, regional, and national burden of breast cancer among females, 1990鈥�2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
2024 (3)
- Burden of disease scenarios for 204 countries and territories, 2022鈥�2050: a forecasting analysis for the Global Burden of Disease Study 2021
- Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950鈥�2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
- Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990鈥�2021: a systematic analysis for the Global Burden of Disease Study 2021
2023 (4)
- Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications
- Medicinal and mechanistic overview of artemisinin in the treatment of human diseases
- Therapeutic strategies for rheumatic diseases and disorders: targeting redox imbalance and oxidative stress
- Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy
2022 (12)
- Recent advances in the therapeutic potential of emodin for human health
- Sesquiterpenoid lactones as potential anti-cancer agents: an update on molecular mechanisms and recent studies
- Nutraceutical Profiling, Bioactive Composition, and Biological Applications of Lepidium sativum L.
- Biosynthesized silver nanoparticles and miR34a mimics mediated activation of death receptor in MCF-7 human breast cancer cell lines
- Natural Compounds or Their Derivatives against Breast Cancer: A Computational Study
- The global burden of cancer attributable to risk factors, 2010鈥�19: a systematic analysis for the Global Burden of Disease Study 2019
- Pharmacological Properties of Bergapten: Mechanistic and Therapeutic Aspects
- Biosynthesis of Secondary Metabolites Based on the Regulation of MicroRNAs
- Urtica dioica -Derived Phytochemicals for Pharmacological and Therapeutic Applications
- Propolis: An update on its chemistry and pharmacological applications
- Artemisia spp.: An Update on Its Chemical Composition, Pharmacological and Toxicological Profiles
- The effects of thymoquinone on pancreatic cancer: Evidence from preclinical studies